$CAPR:NASDAQ · CAPRICOR THERAPEUTICS, INC.
Conviction from: NASDAQ
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical…
More about this company
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatment of DMD. The company also develops Exosome protein-based vaccine, which is in preclinical trial to treat SARS-CoV-2; StealthX Exosome Platform, and exosome platform program consists of engineered exosomes for vaccine and therapeutic development and is in preclinical trial. In addition, it engages in developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases; It has license agreement with Johns Hopkins University, University of Rome License, and Cedars-Sinai Medical Center to develop and commercialize licensed products and licensed services under the licensed patent rights in all fields and a nonexclusive right to the know-how; Cell Line License Agreement with Life Technologies for the development of exosomes platform. The company was founded in 2005 and is headquartered in San Diego, California.
Not currently held by tracked 13F filers — this page aggregates activist, insider, politician and research activity.
Beyond 13F — activists, insiders, politicians & research
Watching · 1 mention(s), 0 personal-position post(s) · first 2026-09-06 · last 2026-09-06
“I asked OpenAI Astra Ultra + Anthropic Fable 5.1 Max to make me a 5x-10x return type portfolio in 1 year.
Burnt a lot of credits, and the results are in:
OpenAI: - $KYTX (autoimmune CAR-T results)
- $PRQR (human RNA-editing datasets)
- $VSTM (KRAS cancer-drug)
- $CNTB (asthma and COPD)
- $RANI (oral biologics)
- $IVA (MASH)
- $SILC (networking + inference hardware)
- $AMPX (batteries)
- $EOSE …” post →
All 1 tweet(s) mentioning this ticker
| Date | Tweet |
|---|
| 2026-09-06T14:23:02 | I asked OpenAI Astra Ultra + Anthropic Fable 5.1 Max to make me a 5x-10x return type portfolio in 1 year.
Burnt a lot of credits, and the results are in:
OpenAI: - $KYTX (autoimmune CAR-T results)
- $PRQR (human RNA-editing datasets)
- $VSTM (KRAS cancer-drug)
- $CNTB (asthma and COPD)
- $RANI (… → · 4993 likes · 1,338,791 views |